Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.
about
Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ)Bisphosphonates in multiple myeloma: a network meta-analysisInterventions for treating osteonecrosis of the jaw bones associated with bisphosphonatesBisphosphonates: mechanism of action and role in clinical practiceCell Fate and Differentiation of Bone Marrow Mesenchymal Stem CellsBisphosphonate Related Osteonecrosis of the Jaw: An UpdateOsteochemonecrosis: an overviewBisphosphonate drug holiday: choosing appropriate candidatesBone targeted therapies for the prevention of skeletal morbidity in men with prostate cancerJaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case reportAntiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.Use of Ultrasonic Bone Surgery (Piezosurgery) to Surgically Treat Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ). A Case Series Report with at Least 1 Year of Follow-Up.Existing data sources for clinical epidemiology: Scandinavian Cohort for osteonecrosis of the jaw - work in progress and challenges.Bisphosphonate-related osteonecrosis of the jaw: data from the French national pharmacovigilance database.Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonatesBisphosphonate-induced osteonecrosis of the jaws: review, clinical implications and case report.Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects.Low-level laser therapy supported teeth extractions of two patients receiving IV zolendronate.Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench.Meaning and Limitation of Cortical Bone Width Measurement with DentaScan in Medication-Related Osteonecrosis of the Jaws.The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UKA pilot case-control study on the alveolar bone density measurement in risk assessment for bisphosphonate-related osteonecrosis of the jaw.Osteoporosis: "A risk factor for periodontitis"Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.New dimensional staging of bisphosphonate-related osteonecrosis of the jaw allowing a guided surgical treatment protocol: long-term follow-up of 266 lesions in neoplastic and osteoporotic patients from the university of bari.A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosisMultiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysisImplant failure associated with oral bisphosphonate-related osteonecrosis of the jaw.Conservative treatment of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patientsIs bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled studyBisphosphonate-related osteonecrosis of the jaw: historical, ethical, and legal issues associated with prescribing.A case of tooth fracture occurred upon medicating bisphosphonate for an elderly person: Preservation therapy and responses for Stage 0 of bisphosphonate-related osteonecrosis of jaw.Osteonecrosis of the jaw in a patient on Denosumab.Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary.Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report.Treatment of bisphosphonate-induced osteonecrosis of the jaws with Nd:YAG laser biostimulation.Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.Bone health and prostate cancer.Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: a pilot study comparing fibrin rich in growth factors and teriparatide.
P2860
Q24186105-D2AD7D73-3707-4507-A860-8E2E7926588DQ24197839-18F1BD06-73AA-4DE7-B4C1-0581BF354326Q24236073-02AF0C4F-7094-41A6-9EE1-BFB7E086F935Q24644708-099763BC-57A1-4611-B6AB-0DE1567FDE3DQ26746170-F16E33E7-16B3-4949-90DD-5A842CB41981Q26801664-FE9F0A50-CFC3-442A-A365-C6FE6C8037BBQ26827072-1E5AE35E-5EF7-4CC1-8DEB-AD10C90B0130Q27004682-F7C14B82-D7E0-4A1B-BB58-EE915D6B21FEQ27021268-F450B4C7-2F74-46C9-A042-1F24B437F64AQ28275303-E4A0A34F-278C-4E86-88D4-AD886EE28061Q30239854-CE36F4AF-5A5D-4CBC-98BB-AE0A9AA04A6EQ30449286-2E9E3C54-2974-4FC1-9EC8-6AA342869EC9Q30888611-F274C2CD-C981-400F-993E-F582200D03A9Q31108809-7F990C2C-5F94-495E-8623-C37020AFC408Q33553916-47D1D03B-CCFD-4483-A71A-C0F4F40E8A7AQ33594764-6C67466D-C7C6-47F7-A3D9-2E6488C337FEQ33594793-5A4DF7EB-812D-47A2-A62C-9859D419876AQ33644664-BA7D2E4A-A056-4950-9431-77F2F0BDDEA8Q33666457-309E6D80-05A9-47D9-B4AC-51E032363FC2Q33703167-F14E84C1-C60F-4193-9385-7BE7F9287D14Q33706654-DC162B0E-F27A-44BE-BDF8-CC6EC3473881Q33756363-67C1204F-9604-4CAC-B1D2-BF8CF423CC24Q33759893-E05615DE-DCD7-4D7D-9046-C0F5252CD92FQ33771321-27030895-C5B3-4D73-A0BF-EBD44F4EAA9AQ33796816-97F77537-C0A7-4F89-B1BE-BFC0B62E0C02Q33810748-D748B02B-E86C-4501-AAF9-EEDC0343C34AQ33854017-EA7A3921-B267-469A-BBFA-8AA117407B63Q33861392-683156F8-4643-4B38-AFA2-C2566BC592B7Q33865551-9DD109EF-73EB-4FCF-8B55-A878343C1417Q33866456-DE63BFDB-DC3A-4569-8A71-0ED3D4C9806EQ33885770-30EE5C78-C902-419F-8F52-C611AD4632A4Q33886905-D1F7357C-16AD-49BD-93A7-1684FE96181EQ33891868-E5BAB156-6C24-4A6D-BE3E-987B597104F3Q33892631-486538E7-3CCC-4AA9-A4D7-F6D400893D1AQ33898150-7B4F447F-8A7F-495F-940E-77EEF04C02B8Q33906777-655A95F2-997D-44D5-9DC3-937F481ABB5DQ33947252-AB9A2AC8-7ED1-4404-A18D-3CAD46807851Q33977536-C72A434C-6D05-4E1C-B630-9B7B39FB7D67Q33978439-2A954542-D6F7-4985-A3A6-AC816C8C4BBCQ33991128-5E8B31FC-D88A-4554-B555-7F5FB45CE7A7
P2860
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Pamidronate (Aredia) and zoled ...... the jaws: a growing epidemic.
@en
Pamidronate
@nl
type
label
Pamidronate (Aredia) and zoled ...... the jaws: a growing epidemic.
@en
Pamidronate
@nl
prefLabel
Pamidronate (Aredia) and zoled ...... the jaws: a growing epidemic.
@en
Pamidronate
@nl
P1476
Pamidronate (Aredia) and zoled ...... the jaws: a growing epidemic.
@en
P2093
Robert E Marx
P304
P356
10.1016/S0278-2391(03)00720-1
P407
P577
2003-09-01T00:00:00Z